Taste changes and eating habits on weight loss drugs
Part of Hormones & metabolism clinical trials.
This study looks at how GLP-1 medications (like semaglutide/Wegovy or tirzepatide/Mounjaro) change your sense of taste and eating habits while losing weight. If you are 18–60, have obesity, and have been taking one of these drugs for at least 12 weeks, you may qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You have been diagnosed with obesity
- You are taking a GLP-1 medication (like semaglutide/Wegovy/Ozempic or tirzepatide/Mounjaro)
- You have been on this medication for at least 12 weeks
- Your clinic has your diet and treatment records from that time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
This study tests whether gradually lowering the dose of the weight-loss drug semaglutide can help people who have already lost weight keep it off. You may join if you are already taking weekly semaglutide and have lost at least 10% of your starting weight or are at a healthy weight after losing 5%.
This trial tests a new way to deliver semaglutide through a strip placed on the tongue for weight loss in adults with obesity. It may help you lose weight without a needle.
This study looks at how weight loss medications (semaglutide or tirzepatide) affect your appetite and the hormones that control it. The goal is to better understand why these medicines help people lose weight.
This study compares how a GLP-1 medication (a drug that helps control blood sugar and weight) changes the way your body stores and uses fat. Researchers will use imaging scans to see these changes over time in people with metabolic syndrome—a cluster of health conditions including high blood pressure, high cholesterol, and excess weight.
This trial looks at how two weight-loss medications, semaglutide and tirzepatide, affect your body's fat and muscle. It may help you understand if these medications improve your overall health beyond just weight loss.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.